Atsushi Sugiyama

Utilization of telemetry system to assess the cardiovascular profile of AH-1058, a new cardioselective Ca2+ channel blocker, in conscious dogs.

H. Dohmoto, Akira Takahara, Ryota Yoshimoto, 2001, Japanese journal of pharmacology.

Sensitive and reliable proarrhythmia in vivo animal models for predicting drug‐induced torsades de pointes in patients with remodelled hearts

A. Sugiyama, Atsushi Sugiyama, 2008, British journal of pharmacology.

No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic‐AV block

M. Vos, M. Thomsen, A. Sugiyama, 2006, British journal of pharmacology.

Effects of nonsedating antihistamine, astemizole, on the in situ canine heart assessed by cardiohemodynamic and monophasic action potential monitoring.

K. Hashimoto, N. N. Aye, A. Sugiyama, 1997, Toxicology and applied pharmacology.

Effects of ONO-2235, an aldose reductase inhibitor, on muscarinic receptors and contractile response of the urinary bladder in rats with streptozotocin-induced diabetes.

K. Eto, K. Hashimoto, N. Tanabe, 1997, Japanese journal of pharmacology.